Data as of Nov 25
| +0.02 / +0.31%|
The 7 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 9.50, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +48.67% increase from the last price of 6.39.
The current consensus among 7 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.